Management of Chemotherapy associated Anemia through Nagaphani fruit

Pharmaco-therapeutic evaluation of Nagaphani( Opuntia elatior Mill.) fruit in Pandu with special reference to its efficacy in Cancer and Chemotherapy associated Anemia

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/07/026593

Enrollment

Registered

2020-07-15

Start date

Unknown

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D648- Other specified anemias

Interventions

Intervention1: In Group A Nagaphani Phala Swarasa( fruit juice): In Group A Nagaphani Phala Swarasa( fruit juice) 40ml/day in two divided before meal for the duration of 60 days will be given orally C

Eligibility

Inclusion criteria

Inclusion criteria: Any type of Cancer patients under Chemotherapy associated with Anemia Hb% below 12gm for female and below 13gm for male or reduced RBC count

Exclusion criteria

Exclusion criteria: Patient who are not under Chemotherapy Pregnancy and Lactation Severe Renal/Hepatic/Cardiac disease Any continuing blood loss Hemoglobin percentage below 6gm

Design outcomes

Primary

Measure	Time frame
Increase in Hb percentageTimepoint: 60 days	—

Secondary

Measure	Time frame
Increased RBC countTimepoint: 60 days	—

Countries

India

Contacts

Public ContactProf Rabinarayan Acharya

Institute of Post Graduate Teaching and Research in Ayurveda

drrnacharya@gmail.com9924585855

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026